Authors: Rocha-Singh, K

Citation: K. Rocha-singh, Vertebral artery stenting: Ready for prime time?, CATHET C IN, 54(1), 2001, pp. 6-7

Authors: Lederman, RJ Tenaglia, AN Anderson, RD Hermiller, JB Rocha-Singh, K Mendelsohn, FO Hiatt, WR Moon, T Whitehouse, MJ Annex, BH

Citation: Rj. Lederman et al., Design of The Therapeutic Angiogenesis With Recombinant Fibroblast Growth Factor-2 for Intermittent Claudication (TRAFFIC) trial, AM J CARD, 88(2), 2001, pp. 192

Authors: Henry, TD Rocha-Singh, K Isner, JM Kereiakes, DJ Giordano, FJ Simons, M Losordo, DW Hendel, RC Bonow, RO Eppler, SM Zioncheck, TF Holmgren, EB McCluskey, ER

Citation: Td. Henry et al., Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease, AM HEART J, 142(5), 2001, pp. 872-880

Authors: Hendel, RC Henry, TD Rocha-Singh, K Isner, JM Kereiakes, DJ Giordano, FJ Simons, M Bonow, RO

Citation: Rc. Hendel et al., Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion - Evidence for a dose-dependent effect, CIRCULATION, 101(2), 2000, pp. 118-121

Authors: Lucore, CL Mishkel, GJ Ligon, RW Rocha-Singh, K

Citation: Cl. Lucore et al., Economic implications of coronary stenting with adjunctive IIb/IIIa receptor antagonists in a community hospital, J INVAS CAR, 11, 1999, pp. 14C-20C